Patient guide · Heart failure
Heart failure medications: what each one does
A plain-language tour of the medicines used for heart failure, what they do, what the studies showed, and the common worries people have about them.
What heart failure medications is, in plain language
Heart failure medications fall into two groups: the four "pillar" drug classes proven to help everyone with reduced ejection fraction (HFrEF), and additional medicines used in specific situations, such as fluid buildup, a slow-improving response, or a recent hospitalization.
Understanding what each medicine does, and why it is prescribed alongside the others rather than instead of them, makes it easier to recognize guideline-based care.
What the current guidelines recommend
The main guideline is the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, updated by the 2024 ACC Expert Consensus Decision Pathway, which lists specific medicines within each recommended class and gives guidance on which additional therapies suit which patients.
The treatments, and why each one is recommended
The four pillars (for HFrEF, used together):
- ARNI (sacubitril/valsartan), or an ACE inhibitor or ARB: relaxes blood vessels and blocks hormones that make heart failure worse.
- Beta blocker (carvedilol, metoprolol succinate, or bisoprolol): slows the heart and lets it fill and work more efficiently over time.
- MRA (spironolactone, eplerenone): blocks a hormone (aldosterone) that causes fluid retention and scarring of heart tissue.
- SGLT2 inhibitor (dapagliflozin, empagliflozin): originally a diabetes medicine, shown to reduce heart failure hospitalizations and death regardless of blood sugar.
Additional medicines for selected patients:
- Hydralazine plus isosorbide dinitrate: an add-on, especially for Black patients with persistent symptoms, or an alternative when ARNI, ACE inhibitors, and ARBs cannot be used.
- Ivabradine: lowers heart rate directly when it stays above 70 despite a maximum tolerated beta blocker dose.
- Vericiguat: for heart failure that is worsening despite the pillars, especially after a recent hospitalization or IV diuretic use.
- Digoxin: reduces hospitalizations for persistent symptoms; it does not lower the risk of death.
- Diuretics (furosemide, torsemide, bumetanide): relieve fluid buildup and shortness of breath; the dose is adjusted to your weight and symptoms, not fixed.
- IV iron: corrects iron deficiency, common in heart failure, improving symptoms and exercise capacity.
What guideline-based care looks like at a visit
A good clinician can explain, medicine by medicine, why you are on each one and what it is doing. Diuretic doses should flex with your weight and symptoms rather than stay fixed indefinitely. If you are on digoxin, hydralazine/nitrates, ivabradine, or vericiguat, that should be because the four pillars alone were not enough, not in place of them.
Red flags that a clinician is not following the guidelines
- Selling supplements, peptides, or compounded drugs as treatment
- Stopping proven medicines without a medical reason
- Ordering unproven tests or “detox” programs
- Telling you the guidelines are wrong without evidence
- Stopping a pillar medicine for a mildly abnormal lab value instead of adjusting the dose or timing first
Why choosing a guideline-based clinician matters
Each pillar medicine was proven in its own large randomized trial to reduce death or hospitalization; used together, their benefits are additive rather than redundant. A clinician who understands this prescribes the full combination and the additional medicines that fit your specific situation, instead of treating heart failure with a single drug.
Questions to ask your doctor
- Which guideline do you follow for heart failure medications, and what year is it from?
- Which of the recommended treatments am I on, and if not, why not?
- What targets are we aiming for, and how will we track them?
- What should make me call you before my next visit?
- Do you sell any supplements or compounded medicines? (A guideline-based clinic does not.)
Find a vetted heart failure specialist near you
Every heart failure specialist on DoctorDirectory.ai is license-verified, board-certified, and has signed a dated attestation to these guidelines. No patient reviews or star ratings, just facts you can check.
The guidelines behind this guide
Summaries in plain language, with links to the official documents and PDFs.
American College of Cardiology · 2024
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
- A practical guide to starting all four heart failure medicines quickly, often within weeks, rather than one at a time over months.
- Explains how to handle low blood pressure, kidney numbers, and potassium so medicines are adjusted rather than stopped.
- Sets out when to refer to an advanced heart failure team.
Read the guidelinedoi:10.1016/j.jacc.2023.12.024AHA / ACC / HFSA · 2022
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- For heart failure with reduced pumping (HFrEF), four medicine classes are recommended together: an ARNI (or ACE inhibitor or ARB), a beta blocker, an MRA, and an SGLT2 inhibitor.
- Each of the four lowers death and hospital stays on its own; together the benefit is large.
- SGLT2 inhibitors are also recommended for heart failure with preserved pumping (HFpEF), which had few options before.
- Devices (ICD, CRT), cardiac rehab, and treating iron deficiency are covered for the right patients.
Find a vetted heart failure specialist near you
Every heart failure specialist listed has a verified license, board certifications on record, and a dated attestation to these guidelines. No reviews, no ratings.